ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 451

Cross-Sectional and Longitudinal Construct Validity for the Improved Health Assessment Questionnaire Among Adults with Knee Osteoarthritis

Mei Chung1, Augustine C. Lee2, John B. Wong3, Xingyi Han4 and Chenchen Wang2, 1Department of Public Health and Community Medicine, Tufts University School of Medicine, Boston, MA, 2Rheumatology, Tufts Medical Center, Boston, MA, 3Tufts Medical Center, Boston, MA, 4Public Health and Community Medicine, Tufts University, Boston, MA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Clinical research methods, Health Assessment Questionnaire, osteoarthritis and patient-reported outcome measures, Validity

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2016

Title: Quality Measures and Quality of Care - ARHP Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

 

Background/Purpose: The improved Health Assessment Questionnaire (iHAQ) is a novel version of the HAQ (ACR-recommended metric of physical function for RA) based on Item Response Theory. However, there is limited evidence examining its performance in OA. Our purpose was to evaluate the cross-sectional and longitudinal construct validity of the iHAQ in knee OA.

Methods: In a randomized trial comparing Tai Chi with physical therapy among adults with symptomatic knee OA (ACR criteria), we pooled the similar treatment effect that was found and performed a cross-sectional and longitudinal analysis. Participants completed the iHAQ, Patient Global Assessment, Short Form-36, and WOMAC at baseline and after 12 weeks. We examined two iHAQ scoring methods: method A used all 20 items, method B used 16 (Range: 0-100; 100=more disability). Applying the Consensus-based Standards for the Selection of Health Measurement Instruments (COSMIN) standard to assess cross-sectional construct validity, we tested 6 a priori hypotheses with the expected Spearman’s correlations between iHAQ scores and legacy scores at 12 weeks. After a comparison of instruments, we formulated each hypothesis with the direction, strength, and rationale for expected correlation. Longitudinal construct validity was investigated similarly but used correlations in score changes from baseline to 12 weeks. Cross-sectional or longitudinal construct validity was based on number of confirmed hypotheses: High, 5-6 of 6 (>80%); Moderate, 3-4 of 6 (80-35%); or Poor, 0-2 of 6 (<35%).

Results: In 159 participants (71% female, 57% white, mean age 61 years), the 12-week median (Interquartile Range) iHAQ scores were respectively 12.5 (3.1, 25) and 9.4 (1.6, 23) for A and B methods. The change scores from baseline were -4.7 (-15.6, 3.1) for A; and -3.1 (-12.5, 3.1) for B. All associations were in the anticipated direction (Table 1). Affirming high cross-sectional construct validity, all 6 respective hypotheses (100%) were confirmed for both A and B methods (Table 2). Indicating high longitudinal construct validity, 5 of 6 respective hypotheses (83%) were confirmed (Table 3).

Conclusion: iHAQ is able to measure its intended construct and detect changes over time among those with knee OA, which supports its consideration as a novel, recommended outcome instrument in OA.      

Table 1. Spearman’s Correlations between iHAQ and Legacy Measures

Legacy Measure

iHAQ Method A†, rho

iHAQ Method B†, rho

SF-Physical Function* (Score range: 0-100)

-0.6604

-0.6729

 

Change SF-Physical Function -0.4757 -0.4868
SF-Mental Health

(Score range: 0-100)

-0.3812 -0.3795  
Change SF-Mental Health -0.3042 -03278
WOMAC function

(Score range: 0-1700)

0.5404 0.5487
Change WOMAC function 0.4972 0.5212
SF-Role Physical (Score range: 0-100mm) -0.4629 -0.4830
Change SF-Role Physical   -0.3734 -0.3864
Patient Global (Score range: 0-10cm) 0.4946 0.5363
Change Patient Global 0.3055 0.3299

*Cross-sectional scores were taken at 12-week follow-up. †Change iHAQ scores were correlated with change legacy measures. Change scores reflected change from baseline to 12 weeks.  Note: Consensus guidelines from COSMIN do not recommend reporting p values of correlation coefficients for the purposes of instrument validation. 

                                                   

Table 2. Hypotheses for Cross-Sectional Construct Validity of the Improved HAQ

Hypotheses

Rationale

Correlation Result(s)

Confirmed?

1. There will be a strong* (≥ 0.5) negative correlation between iHAQ and Short Form (SF)-Physical Function after intervention

iHAQ and SF-Physical Function attempt to measure similar constructs

Expect‡≥ 0.50

Method A: -0.66

Method B: -0.67

Yes

2. The positive correlation between iHAQ with SF-Physical Function will be at least 0.1 higher than the correlation between iHAQ with SF-Mental Health

iHAQ and SF-Physical Function attempt to measure similar constructs, but iHAQ and SFMH attempt to measure unrelated constructs   Expect ≥ 0.10

Method A: 0.28

Method B: 0.29

Yes

3. There will be at least a mod-strong (≥ 0.4) positive correlation between iHAQ and WOMAC Function after intervention. 

iHAQ and WOMAC Function attempt to measure similar constructs, but the WOMAC function is lower limb-specific   Expect≥ 0.40

Method A: 0.54

Method B: 0.55

Yes

4. There will be at least a moderate (≥ 0.3) positive correlation between iHAQ and WOMAC Pain after intervention. 

 

iHAQ and WOMAC Pain attempt to measure loosely-related constructs   Expect≥ 0.30

Method A: 0.49

Method B: 0.51

Yes

5. There will be at least a moderate (≥ 0.3) negative correlation between iHAQ and SF-Role Physical after intervention.

iHAQ and SF-Role Physical attempt to measure loosely-related constructs Expect≥ 0.30

Method A: -0.46

Method B: -0.48

Yes

6. There will be at least a weak-moderate (≥ 0.2) positive correlation between iHAQ and Patient Global Assessment after intervention.

iHAQ and Patient Global Assessment attempt to measure partially related constructs, Expect≥ 0.20

Method A: 0.49

Method B: 0.54

Yes

Cross-Sectional Construct Validity Rating: High†

Hypotheses Confirmed: 6 of 6; 100%

*Correlation strength: r ≥ 0.5, Strong; 0.5 > r ≥ 0.4, Moderate-Strong; 0.4 > r ≥ 0.3, Moderate; 0.3 > r ≥ 0.2, Weak-Moderate; 0.2 > r ≥ 0.1, Weak; and 0.1 > r, Negligible. †Overall construct validity was assigned based on percent of total hypotheses confirmed:  High, (5-6 of 6 (≥75%); Moderate, 3-4 of 6 (50%≤ x <75%); or Poor, 0-2 of 6 (<50%). .‡For clarity, ”Expect” values are expressed as absolute values.

 

 

Table 3. Hypotheses for Longitudinal Construct Validity of the Improved HAQ

Hypotheses

Rationale

Correlation Result(s)

Confirmed?

1. There will be a strong* (≥ 0.5) negative correlation between change of iHAQ and change of Short Form (SF)-Physical Function

iHAQ and SF-Physical Function attempt to measure similar constructs

Expect.‡ ≥ 0.50

Method A: -0.48

Method B: -0.49

 

No

2. The positive correlation of change on the iHAQ with that of the SF-Physical Function will be at least 0.1 higher than the correlation of change on the iHAQ with the SF-Mental Health

iHAQ and SF-Physical Function attempt to measure similar constructs, but iHAQ and SF-Mental Health attempt to measure unrelated constructs   Expect ≥ 0.10

Method A: 0.17

Method B: 0.16

Yes

3. There will be at least a moderate-strong (≥ 0.4) positive correlation between change of iHAQ and change of WOMAC Function

iHAQ and WOMAC-Function attempt to measure similar constructs, but the WOMAC function is lower limb-specific   Expect≥ 0.40

Method A: 0.497

Method B: 0.52

Yes

4. There will be at least a moderate (≥ 0.3) positive correlation between change of iHAQ and change of WOMAC Pain

iHAQ and WOMAC Pain attempt to measure loosely-related constructs   Expect≥ 0.30

Method A: 0.43

Method B: 0.44

Yes  

5. There will be at least a moderate (≥ 0.3) negative correlation between change of iHAQ and of SF Role Physical

iHAQ and SF-Role Physical attempt to measure loosely-related constructs Expect≥ 0.30

Method A: -0.37

Method B: -0.39  

Yes

6. There will be at least a weak-moderate (≥ 0.2) positive correlation between change of iHAQ and change of Patient Global Assessment

iHAQ and Patient Global Assessment attempt to measure partially related constructs Expect≥ 0.20

Method A: 0.31

Method B: 0.33

Yes  

Longitudinal Construct Validity Rating: High†

Hypotheses Confirmed: 6 of 6; 100%

*Correlation strength: r ≥ 0.5, Strong; 0.5 > r ≥ 0.4, Moderate-Strong; 0.4 > r ≥ 0.3, Moderate; 0.3 > r ≥ 0.2, Weak-Moderate; 0.2 > r ≥ 0.1, Weak; and 0.1 > r, Negligible. †Overall construct validity was assigned based on percent of total hypotheses confirmed:  High, (5-6 of 6 (≥75%); Moderate, 3-4 of 6 (50
%≤ x <75%); or Poor, 0-2 of 6 (<50%). .‡For clarity, ”Expect” values are expressed as absolute values.

 

 


Disclosure: M. Chung, None; A. C. Lee, National Institutes of Health., 2; J. B. Wong, None; X. Han, None; C. Wang, National Institutes of Health, 2.

To cite this abstract in AMA style:

Chung M, Lee AC, Wong JB, Han X, Wang C. Cross-Sectional and Longitudinal Construct Validity for the Improved Health Assessment Questionnaire Among Adults with Knee Osteoarthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/cross-sectional-and-longitudinal-construct-validity-for-the-improved-health-assessment-questionnaire-among-adults-with-knee-osteoarthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cross-sectional-and-longitudinal-construct-validity-for-the-improved-health-assessment-questionnaire-among-adults-with-knee-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology